Vagal Nerve Stimulation for the Treatment of Persistent AF
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.
Also called NCT05833373
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 120 participants
- Registry
-
NCT05833373
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Germany
- Registry status
- Unknown status
Technical summary
Registry record NCT05833373. Randomized; triple masking; primary purpose treatment. Start 2023-11-06 (actual); primary completion 2025-11-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Vagal Nerve Stimulation for the Treatment of Persistent AF
- Acronym
- VAST-AF
- Condition
- Atrial Fibrillation
- Intervention (Device)
- Vagal stimulation with the device tVNS from tVNS Technologies GmbH
- Intervention (Device)
- Sham stimulation with the device tVNS from tVNS Technologies GmbH
- Lead sponsor
- Krankenhaus Hetzelstift
- Collaborator
- Deutsche Stiftung für Herzforschung
- Collaborator
- Johannes Gutenberg University Mainz
Record details
- Record id
cardio:ct-nct05833373- Content hash
2339125968b4f6dc97e4d86d6dce3e0305b218ce757e12e75ba2e82305463901